Raynovent Announces Receiving of Certificate of Invention Patent

Previous:Raynovent Announces Initiation of Phase 2 Clinical Trial of ZSP1273, a Category 1 Drug Intended to Treat and Prevent Influenza A and Human Avian Influenza.

Next:Raynovent Announces Receiving of Certificate of Invention Patent in Russia